Tracheostomy Practices in Adult Intensive Care Units: A Multicenter Point-Prevalence Study in Izmir (IZ-TRACH)
IZ-TRACH
1 other identifier
observational
282
1 country
1
Brief Summary
The primary objective of this study was to determine the point-prevalence of tracheostomy in adult intensive care units (ICUs) in Izmir and to characterize the documented reasons for postponement of tracheostomy, with attention to family-related deferral. Secondary objectives included tracheostomy indications, techniques, complications, timing, the relationship between illness severity (APACHE II) and mortality, and short-term outcomes. This multicenter, descriptive point-prevalence study was conducted across eleven adult ICUs in six hospitals on September 8, 2025. Of 282 adult patients present on the index day, 46 had a tracheostomy and formed the analytic subgroup. The study aimed to provide observational data on how tracheostomy is managed in a real-world clinical setting, focusing on the decision-making process and clinical characteristics associated with patient mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2025
CompletedFirst Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 11, 2026
CompletedJune 22, 2026
June 1, 2026
1 month
February 5, 2026
June 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
30-day in-hospital mortality from the index date
The proportion of patients who died within 30 days of the index (point-prevalence) date. Because tracheostomies were prevalent (established before the survey), this is a point-prevalence snapshot rather than a procedure-anchored rate.
Up to 30 days after the index day
Point-prevalence of tracheostomy and documented reasons for postponement
The proportion of adult ICU patients with a tracheostomy on the index day, and the distribution of documented reasons for postponement of tracheostomy (including family-related deferral).
Day 1
Secondary Outcomes (5)
Intubation-to-tracheostomy interval (days)
From endotracheal intubation to tracheostomy, assessed through Day 1
Distribution of tracheostomy technique (surgical vs percutaneous)
Day 1
Early and late complication rates by technique
From tracheostomy through Day 1
APACHE II score and its discrimination for 30-day mortality
Up to 30 days after the index day
Causes of death among non-survivors
Up to 30 days after the index day
Study Arms (1)
Tracheostomy Patients
Adult patients (aged ≥18 years) hospitalized in intensive care units who have undergone either surgical or percutaneous tracheostomy.
Interventions
The application of surgical or percutaneous dilatational tracheostomy (Griggs guidewire dilating forceps or Ciaglia single-dilator techniques) for indications such as prolonged mechanical ventilation
Eligibility Criteria
Adult patients (aged ≥18 years) present in eleven participating adult intensive care units across six hospitals in Izmir, Turkey, on the point-prevalence day. Patients with a surgical or percutaneous tracheostomy formed the analytic subgroup.
You may qualify if:
- Aged 18 years and older
- Present in a participating adult ICU on the point-prevalence day
You may not qualify if:
- Patients younger than 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir City Hospital
Izmir, Bayrakli, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Murat KAYKAC, M.D.
Izmir City Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 30 Days
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology and Reanimation Specialist, MD
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 11, 2026
Study Start
September 8, 2025
Primary Completion
October 8, 2025
Study Completion
October 8, 2025
Last Updated
June 22, 2026
Record last verified: 2026-06